InSilico jumps on AI drug discovery collaboration
Shares of InSilico Medicine Cayman TopCo jump 7.2% to HK$65.2, the highest level since May 12. The AI-driven drug discovery group is on track for its third straight session of gains, entering into a collaboration with a frontier foundation model lab for tens of millions of U.S. dollars to co-develop, validate, and commercialize foundation models for biological research. The collaboration aims to build specific models for generative biology with a revenue-sharing framework for global commercialization.
2, their highest level since May 12. The AI-driven drug discovery and pipeline development company was on track for a third straight session of gains. S. dollars, to co-develop, validate and commercialize a series of frontier foundation models engineered for biological research.
The collaboration will focus on building specific foundation models for generative biology, and the parties have set up a revenue-sharing framework to support global commercialization across their respective biopharmaceutical partner networks. 9%.